NGeneBio Co., Ltd. (KOSDAQ: 354200)
South Korea
· Delayed Price · Currency is KRW
3,175.00
-225.00 (-6.62%)
Oct 11, 2024, 9:00 AM KST
NGeneBio Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 |
| Oct '24 Oct 10, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 40,923 | 71,664 | 116,027 | 201,381 |
| Market Cap Growth | -51.17% | -38.23% | -42.38% | - |
| Enterprise Value | 49,849 | 56,797 | 89,239 | - |
| Last Close Price | 3175.00 | 5560.00 | 9280.00 | 16200.00 |
| PE Ratio | - | -5.52 | -11.83 | -23.75 |
| PS Ratio | 8.17 | 16.47 | 10.53 | 28.11 |
| PB Ratio | 3.68 | 4.41 | 4.58 | 5.92 |
| P/FCF Ratio | -3.48 | -7.50 | -13.11 | -19.10 |
| P/OCF Ratio | -3.73 | -7.82 | -14.84 | -26.77 |
| EV/Sales Ratio | 9.99 | 13.05 | 8.10 | - |
| EV/EBITDA Ratio | -3.10 | -4.70 | -12.18 | - |
| EV/EBIT Ratio | -2.70 | -4.23 | -10.38 | - |
| EV/FCF Ratio | -4.28 | -5.95 | -10.08 | - |
| Debt / Equity Ratio | 1.02 | 0.70 | 0.45 | 0.21 |
| Debt / FCF Ratio | -1.11 | -1.20 | -1.29 | -0.68 |
| Asset Turnover | 0.12 | 0.09 | 0.22 | - |
| Inventory Turnover | 1.45 | 1.93 | 3.29 | - |
| Quick Ratio | 0.39 | 0.98 | 1.24 | 3.22 |
| Current Ratio | 0.52 | 1.13 | 1.49 | 3.40 |
| Return on Equity (ROE) | -84.20% | -61.88% | -33.17% | - |
| Return on Assets (ROA) | -20.66% | -17.05% | -10.75% | - |
| Return on Capital (ROIC) | -29.48% | -26.03% | -13.78% | - |
| Earnings Yield | -32.62% | -17.82% | -8.43% | -4.19% |
| FCF Yield | -28.44% | -13.33% | -7.63% | -5.24% |
| Buyback Yield / Dilution | -2.29% | -1.66% | -0.89% | - |
| Total Shareholder Return | -2.29% | -1.66% | -0.89% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.